Tutti gli studi
ReclutamentoFASE2INTERVENTISTICO

The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)

The NODE-202 study is a clinical trial exploring a new nasal spray treatment, Etripamil, for children and teenagers (aged 6-17 years old) who experience a rapid heart rate condition known as Paroxysmal Supraventricular Tachycardia (PSVT). This study is in its second phase, meaning it's still an early stage of testing. Researchers want to find out if the nasal spray is effective and safe to use as a single dose when someone is having a PSVT episode. It will involve different age groups, starting with older teenagers and then moving to younger children, carefully checking the right dose and how the body handles the treatment. The goal is to see if this easy-to-use spray could be a helpful option for managing PSVT.

A colpo d'occhio

Stato
Reclutamento
Fase
FASE2
Sponsor
Milestone Pharmaceuticals Inc.
Obiettivo di iscrizione
60
Inizio
11 Dic 2023
Completamento stimato
30 Giugno 2027

Di cosa tratta questo studio?

This study, called NODE-202, is looking into a potential new treatment for a heart condition known as Paroxysmal Supraventricular Tachycardia, or PSVT. If you or your child has PSVT, you'll know that it causes your heart to suddenly beat very quickly. This study is testing a new medicine called Etripamil, which is given as a nasal spray, to see if it can help stop these fast heart episodes. It's a 'Phase 2' study, which means it's an early step in researching new medicines, focusing on whether it works and if it's safe for children and teenagers.

The study involves different age groups, starting with young people aged 12 to 17 years old, and then potentially moving on to younger children aged 6 to 11. The researchers will give a single dose of the nasal spray to participants when they are having a PSVT episode and watch closely to see if it brings their heart rate back to normal. They will also be checking for any side effects and how the body handles the medicine.

The main aim is to find the right dose and make sure the treatment is safe and tolerable for children. By taking part, you or your child could help doctors learn more about managing PSVT and potentially help develop a new, easier way to treat this condition at home.

Punti chiave

  • This study is testing a new nasal spray for fast heartbeats (PSVT) in children and teenagers.
  • It's an early-stage study to check if the medicine works and is safe.
  • Participants will receive a single dose of the nasal spray if they have a PSVT episode.
  • Different age groups from 6 to 17 years old are included.
  • Participation will involve a few hospital visits.
  • You can stop taking part in the study at any time.

Chi può essere idoneo?

To join this study, participants generally need to be male or female, aged between 6 and 17 years old, and have a confirmed diagnosis of PSVT. Their heart condition must specifically involve a part of the heart called the AV node, and any past treatments for PSVT, like surgery, must show that the PSVT can still happen.

There are also some important health conditions that would prevent someone from joining. For example, if you or your child has other serious heart problems like certain types of irregular heartbeats (like atrial fibrillation or Wolff-Parkinson-White syndrome), or if they have had significant heart surgery that left major issues, they wouldn't be able to participate. It's important that participants are able and willing to follow the study's instructions.

For female participants who are old enough to have periods, they would need to have a negative pregnancy test at the start and agree to use effective contraception throughout the study, unless they are not sexually active. These checks are in place to ensure everyone's safety during the trial.

Questo studio potrebbe fare al caso tuo?

Rispondi a queste domande rapide per vedere se potresti essere idoneo. Questo è solo una guida — il team di ricerca prende la decisione finale.

  1. Are you or your child between 6 and 17 years old?
  2. Do you or your child have a confirmed diagnosis of PSVT?
  3. Is your PSVT related to the AV node in the heart?
  4. Do you or your child have other serious heart problems?
  5. Are you or your child able to come to all study appointments?
  6. For females of childbearing potential, are you able to use contraception during the study?
Rispondi a ogni domanda per vedere il tuo risultato.

Cosa comporta la partecipazione?

Taking part in this study would involve a few steps. First, there would be a 'Screening Visit' to check if you or your child meets all the criteria to join. If you're eligible, the main part is the 'Treatment Visit', where, if a PSVT episode occurs, a single dose of the Etripamil nasal spray will be given. During this visit, doctors will carefully monitor the heart and check for any changes or side effects. There might also be blood tests to see how the medicine is processed by the body. After the treatment, there will be a 'Follow-Up/End of Study Visit' to make sure everything is well.

The study itself is divided into different parts and age groups, but each participant will only receive a single dose if they experience a PSVT episode during the trial. The total duration of your individual participation would include these few visits, from the initial checks to the final follow-up, ensuring doctors have all the information they need about the medicine's effects.

Rischi e benefici potenziali

Potential benefits of taking part include helping researchers learn more about how to treat PSVT, which could lead to a new treatment option in the future. You or your child might also receive closer medical attention than usual. However, there are potential risks, just like with any medicine. These could include side effects from the nasal spray, which the doctors will monitor closely. It's important to remember that this is an experimental medicine, and it might not work for everyone. You are free to withdraw from the study at any time, for any reason, without it affecting your usual medical care.

Locations (10)

  • Phoenix Children's Hospital
    Codice postale verificato
    Phoenix, Stati Uniti· Reclutamento
  • Ospedale Pediatrico Advocate
    Codice postale verificato
    Oak Lawn, Stati Uniti· Non ancora in fase di reclutamento
  • Cincinnati Children's Hospital Medical Center
    Codice postale verificato
    Cincinnati, Stati Uniti· Non ancora in fase di reclutamento
  • Oregon Health and Science University
    Codice postale verificato
    Portland, Stati Uniti· Reclutamento
  • Le Bonheur Children's Hospital
    Codice postale verificato
    Memphis, United States· Non ancora in fase di reclutamento
  • Baylor College of Medicine
    Codice postale verificato
    Houston, Stati Uniti· Non ancora in fase di reclutamento
  • The University of British Columbia
    Codice postale verificato
    Vancouver, Canada· Non ancora in fase di reclutamento
  • Universitätsmedizin Göttingen, Klinik für Pädiatrische Kardiologie, Intensivmedizin und Neonatologie
    Codice postale verificato
    Göttingen, Germany· Non ancora in fase di reclutamento
  • Hospital Sant Joan de Déu
    Codice postale verificato
    Barcellona, Spagna· Non ancora in fase di reclutamento
  • Hospital Infantil Universitario La Paz
    Codice postale verificato
    Madrid, Spagna· Reclutamento

Domande comuni

What is PSVT?

PSVT stands for Paroxysmal Supraventricular Tachycardia, which is a condition where the heart suddenly beats very fast and then returns to a normal rhythm.

What is Etripamil nasal spray?

Etripamil nasal spray is a new medicine being tested in this study to see if it can help stop episodes of fast heartbeats caused by PSVT when sprayed into the nose.

Will I or my child definitely get the new medicine?

If eligible, participants will receive a single dose of the Etripamil nasal spray during the study, specifically when experiencing a PSVT episode.

How long does the study last for each person?

Each participant's involvement includes a screening visit, a treatment visit where the medicine is given (if a PSVT episode occurs), and a follow-up visit. The exact timeframe will vary but will be discussed with you.

Is this medicine available to the public?

No, Etripamil is currently an experimental medicine and is only available to patients participating in specific clinical trials like this one.

Come saperne di più

Cameron Szakacs, PhD

Parla sempre con il tuo medico di base o specialista prima di decidere di partecipare a uno studio.

Interessato a partecipare?

Registrati per ricevere aggiornamenti

Condividi i tuoi dettagli e il team di ricerca per "The NODE-202 Study (Study of Etripamil Nasal Spray in Pediat…" ti contatterà se potresti essere idoneo. Parla sempre con il tuo medico prima di accettare di partecipare.

Discussione

Discussione della comunità

Supportato dal nostro forum su community.patient.info. Si prega di essere rispettosi — questo non è un consiglio medico.